Analysis Of Income And Expense [Abstract]

Affluent Medical - Filing #882835

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
- EUR
- EUR
Material income and expense [abstract]
Finance income (cost)
Other finance income (cost)
4,000 EUR
32,000 EUR
Gains (losses) on change in fair value of derivatives [abstract]
Gains (losses) on change in fair value of derivatives
1 041 EUR
597,000 EUR
Expenses by nature [abstract]
Raw materials and consumables used
2 518 EUR
3 108 EUR
Classes of employee benefits expense [abstract]
Employee benefits expense
4 405 EUR
4 694 EUR
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense
2 420 EUR
1 907 EUR
Impairment loss (reversal of impairment loss) recognised in profit or loss
98,000 EUR
125,000 EUR
Tax expense other than income tax expense
88,000 EUR
67,000 EUR
Other expenses, by nature
5 496 EUR
3 563 EUR
Disclosure of attribution of expenses by nature to their function [text block]
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, before tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, before tax, exchange differences on translation of foreign operations
1,000 EUR
3,000 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]
Share of profit (loss) of associates and joint ventures accounted for using equity method
14,000 EUR
398,000 EUR
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
- EUR
14 820 EUR
32,000 EUR
- EUR
- EUR
1,000 EUR
14 787 EUR
14 787 EUR
- EUR
14 324 EUR
3,000 EUR
- EUR
- EUR
14 319 EUR
14 324 EUR
2,000 EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
14 787 EUR
14 324 EUR
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests
- EUR
- EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.